Myriad Genetics
MYGN
MYGN
218 hedge funds and large institutions have $640M invested in Myriad Genetics in 2025 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 74 increasing their positions, 71 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% less funds holding
Funds holding: 219 → 218 (-1)
3.04% less ownership
Funds ownership: 98.15% → 95.11% (-3%)
Holders
218
Holding in Top 10
1
Calls
$954K
Puts
$139K
Top Buyers
| 1 | +$8.86M | |
| 2 | +$5.81M | |
| 3 | +$5.42M | |
| 4 |
Goldman Sachs
New York
|
+$5.16M |
| 5 |
RA
Royce & Associates
New York
|
+$3.98M |
Top Sellers
| 1 | -$8.16M | |
| 2 | -$6.76M | |
| 3 | -$6.64M | |
| 4 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
-$6.18M |
| 5 |
Morgan Stanley
New York
|
-$5.56M |
